Stockreport

Madrigal Pharma up 13% on positive data on NASH drug resmetirom [Seeking Alpha]

Madrigal Pharmaceuticals, Inc.  (MDGL) 
Last madrigal pharmaceuticals, inc. earnings: 2/26 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: madrigalpharma.com
PDF Thinly traded Madrigal Pharmaceuticals (NASDAQ:MDGL13%announcementPhase 2 clinical trialOnce-daily oral treatment of 80 mg or 100 mg of resmetirom (doses being tested in [Read more]